This company listing is no longer active
ISLE Stock Overview
Isleworth Healthcare Acquisition Corp. does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Isleworth Healthcare Acquisition Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.01 |
| 52 Week High | US$10.14 |
| 52 Week Low | US$9.70 |
| Beta | 0 |
| 11 Month Change | 0.30% |
| 3 Month Change | 0.81% |
| 1 Year Change | 2.35% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 3.20% |
Recent News & Updates
Shareholder Returns
| ISLE | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0% | 2.5% | 1.6% |
| 1Y | 2.4% | 55.7% | 32.3% |
Return vs Industry: ISLE exceeded the US Capital Markets industry which returned -21% over the past year.
Return vs Market: ISLE exceeded the US Market which returned -16.7% over the past year.
Price Volatility
| ISLE volatility | |
|---|---|
| ISLE Average Weekly Movement | 0.5% |
| Capital Markets Industry Average Movement | 3.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ISLE has not had significant price volatility in the past 3 months.
Volatility Over Time: ISLE's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Bob Whitehead | isleworthhealthcare.com |
Isleworth Healthcare Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a business in the biopharmaceutical or medical technology/device industries.
Isleworth Healthcare Acquisition Corp. Fundamentals Summary
| ISLE fundamental statistics | |
|---|---|
| Market cap | US$262.17m |
| Earnings (TTM) | US$10.50m |
| Revenue (TTM) | n/a |
25.0x
P/E Ratio0.0x
P/S RatioIs ISLE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ISLE income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$10.50m |
| Earnings | US$10.50m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.40 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -73.0% |
How did ISLE perform over the long term?
See historical performance and comparison